Not yet recruiting
Gastric bypass
Not yet recruitingStudy on the Effects of Apixaban Absorption in Patients Undergoing Roux-en-Y Gastric Bypass Surgery
Registered drugNo placebo
Study on the Effects of Apixaban Absorption in Patients Undergoing Roux-en-Y Gastric Bypass Surgery
Registered drugNo placebo
- Disease:Gastric bypass
- Substances:Andexanet AlfaApixaban+7
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Andexanet Alfa
- Sponsor:Amsterdam UMC Stichting
